Genovior Biotech Corporation

Genovior Biotechnology Corporation facility capabilities & current ongoing production lines

API

Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

Our services include:

1. Process Development
2. Formulation Development
3. Analytical Development
...

PFS, Lyophilization

PROTEIN, INJECTABLE

Biologic, Oncology

Genovior biotech corporation offers services which includes oncology production services. It provides api: process development and production, injectables: formulation development and production of lyophilization and liquid vials, packaging and labeling. Contact us for more information.

1.  Pre-formulation development

2.  Long-acting release delivery system formulation development

3.  Formulation development

Oncology-Azacitidine, Bortezomib, Gemcitabine, Pemetrexed, Fulvestrant    Peptide-Teriparatide, Glucagon, Octreotide Acetate, Terlipressin Acetate,Biologic,  Others

Interviewee：Dr. Steve J.P. Hsu (President of Genovior Biotech)

( * Manufacturing of API for in-house use)ONCOLOGY
Azacitidine*
Bortezomib*
Bendamustine*
Carboplatin
Carfilzomib*
Docetaxel
Epriubicin
Fulvestrant*
...

Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

Our services include:
1. Process Development
2. Formulation Development
3. Analytical Deve...

Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production

6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs

Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate

Interviewee：Dr. Steve J. P. Hsu (President of Genovior Biotech)